Tranxilium 5
Tranxilium 5 is a medicine authorised by Swissmedic under authorisation number 33866. The authorisation holder is Neuraxpharm Switzerland AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 June 1971 and the authorisation is valid without a time limit. ATC code N05BA05 places the medicine in the group Psycholeptics.
| Authorisation number | 33866 |
|---|---|
| Name | Tranxilium 5 |
| Full name | Tranxilium 5, Hartkapseln |
| Authorisation holder | Neuraxpharm Switzerland AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05BA05 |
| First authorisation | 14 June 1971 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tranxilium 5, Hartkapseln | B | 14 June 1971 |
| 2 | Tranxilium 10, Hartkapseln | B | 14 June 1971 |
| 3 | Tranxilium 20, Hartkapseln | B | 18 September 1975 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 71 | 20 | Kapsel(n) | N05BA05 | 01.04.1. | B |
| 72 | 50 | Kapsel(n) | N05BA05 | 01.04.1. | B |
| 73 | 20 | Kapsel(n) | N05BA05 | 01.04.1. | B |
| 74 | 50 | Kapsel(n) | N05BA05 | 01.04.1. | B |
| 75 | 20 | Kapsel(n) | N05BA05 | 01.04.1. | B |
| 76 | 50 | Kapsel(n) | N05BA05 | 01.04.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tranxilium 5 authorised in Switzerland?
Yes. Tranxilium 5 is authorised by Swissmedic under authorisation number 33866, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tranxilium 5 have?
Tranxilium 5 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Tranxilium 5?
The authorisation holder is Neuraxpharm Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.